<Disease><Name>HYPERZINCAEMIA AND HYPERCALPROTECTINAEMIA</Name><Synonym>HYPERZINCEMIA, FAMILIAL DYSALBUMINEMIC</Synonym><OMIM><Number>194470</Number><URL>http://omim.org/entry/194470</URL></OMIM><Orphanet><Number>251523</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=251523</URL></Orphanet><Protein><Number /><URL /></Protein><ExPASy><Number /><URL /></ExPASy><Gene>unknown</Gene><ICD>E83.2</ICD><Summary>very rare ;autosomal dominant ;albumin gene mutation ? (OMIM ;(103600);dysregulation of two members of the large S100 protein family [Sampson B et al. 2002]</Summary><Symptoms><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1180</id><name>Zinc</name><specimen>serum</specimen><value /><min>6.80</min><max>11.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>1181</id><name>Zinc</name><specimen>serum</specimen><value /><min>9.10</min><max>13.70</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1182</id><name>Zinc</name><specimen>serum</specimen><value /><min>9.80</min><max>16.80</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>3622</id><title>Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-assoc</title><author>Holzinger D,</author><journal>J Allergy Clin Immunol</journal><year>2015</year><book /><volume>136</volume><number>5</number><pages>1337-1345</pages><co_aut>et al.</co_aut></literature><literature><id>3623</id><title>The role of calprotectin in pediatric disease</title><author>Vaos G,</author><journal>Biomed Res Int</journal><year>2013</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3624</id><title>Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus</title><author>Isidor B,</author><journal>Acta Paediatr</journal><year>2009</year><book /><volume>98</volume><number>2</number><pages>410-412</pages><co_aut>et al.</co_aut></literature><literature><id>3625</id><title>Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia</title><author>Fessatou S,</author><journal>J Pediatr Hematol Oncol</journal><year>2005</year><book /><volume>27</volume><number>9</number><pages>477-480</pages><co_aut>et al.</co_aut></literature><literature><id>2408</id><title>Calprotectin - a pleiotropic molecule in acute and chronic inflammation</title><author>Striz I</author><journal>Physiol Res</journal><year>2004</year><book /><volume>53</volume><number>3</number><pages>245-253</pages><co_aut>Trebichavsky I</co_aut></literature><literature><id>2407</id><title>Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism</title><author>Sampson B</author><journal>Lancet</journal><year>2002</year><book /><volume>360</volume><number>0</number><pages>1742-1745</pages><co_aut>et al.</co_aut></literature><literature><id>2409</id><title>Hyperzincemia with systemic inflammation: a heritable disorder of calprotectin metabolism with rheumatic manifestations?</title><author>Saito Y</author><journal>J Pediatr</journal><year>2002</year><book /><volume>140</volume><number>2</number><pages>267-269</pages><co_aut>et al.</co_aut></literature><literature><id>780</id><title>Genetic defects related to metals other than copper</title><author>Jochum F,</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>2000</year><book /><volume>0</volume><number>0</number><pages>394-398</pages><co_aut>Lombeck I</co_aut></literature></Literatures></Disease>